The Stockholm stock exchange falls on Thursday morning as a consequence of the Federal Reserve yesterday flagging fewer interest rate cuts next year. Bioarctic is going against the tide and rallying after signing a major agreement with Bristol-Myers Squibb.

After 35 minutes of trading, the OMXS30 index was down 1.23 percent to 2,506.32. During the day, the index has moved within the range of -1.67 percent at the lowest and -1.02 percent at the highest.

The broad OMXSPI was down 1.26 percent.

Share pricePrice changeCommentary
Bioarctic 20,0%Signs global license agreement with Bristol-Myers Squibb. Bioarctic receives upfront payment of $100 million
Fingerprint Cards 9,7%Enters into strategic partnership with Anonybit
Eltel 1,6%Signs framework agreement with the Swedish Transport Administration. The value of the agreement is almost as large as the company's market capitalization
Getinge 0,7%Nordea raises to hold from sell
Humana-0,3%Expects sale of Finnish nursing homes to be finalized Q1 2025
Ericsson-0,5%Stops plans for a billion-dollar construction project in Estonia, according to Fastighetsnytt
Fabege-1,2%Moody's affirms Baa2 and raises outlook to stable
Skanska-1,2%Announces several orders this morning in the US, Norway and Denmark
Norion Bank-2,7%Kepler Cheuvreux initiates coverage with "Keep" and target price SEK 42
Skistar-2,9%Operating loss in line with expectations. Bookings 3% lower than last year
Afry-3,4%Handelsbanken lowers to hold from buy
Electrolux-4,9%Will pay a fine in France of EUR 44.5 million. The amount is covered by a previous provision
Intervacc-46,6%Announced rights issue of SEK 225 million, subscription price SEK 0.85